PHILADELPHIA, PA / ACCESSWIRE / October 31, 2020 / Kaskela Law LLC, announces that it is investigating Pandion Therapeutics, Inc. ("Pandion") (NASDAQ:PAND) on behalf of the company's stockholders.
The investigation seeks to determine whether Pandion and/or the company's officers and directors have violated the securities laws or breached their fiduciary duties and whether Pandion investors have been harmed as a result of such actions.
Pandion stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585 or (888) 715 - 1740, or via email at [email protected], to discuss this investigation and their legal rights and options. Additional information may also be found at http://kaskelalaw.com/case/pandion-therapeutics-inc/.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC, please visit www.kaskelalaw.com.
CONTACT:
D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740
[email protected]
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
SOURCE: Kaskela Law LLC